Loading...
Genpact Ltd is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, hedge funds are selling, and there is no strong positive momentum in the stock price. While the company's financials and dividend growth are positive, the lack of significant catalysts and bearish sentiment suggest holding off on buying for now.
The technical indicators show a bearish trend. The MACD is negatively expanding, RSI is neutral at 20.44, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels, with the nearest support at 35.899 and resistance at 39.712.

The company declared a 10.3% increase in its quarterly dividend, reflecting a commitment to shareholder returns. The Advanced Technology Solutions segment continues to drive growth, as highlighted in the latest analyst reviews.
Hedge funds are selling, with an 805.73% increase in selling activity over the last quarter. Analysts have lowered price targets, and the stock's technical indicators suggest bearish momentum. No recent congress trading data or major influential purchases were noted.
In Q4 2025, Genpact's revenue increased by 5.65% YoY to $1.319 billion, net income grew by 0.83% YoY to $143.09 million, and EPS rose by 3.80% YoY to $0.82. Gross margin improved by 2.33% YoY to 36%.
Analyst sentiment is mixed. Needham maintains a Buy rating but lowered the price target to $50 from $53. Susquehanna has a Neutral rating and reduced the price target to $42 from $50, citing solid execution but slower growth in the core business.